![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 14
2017
Herlemann, A.; Horst, D.; D'Anastasi, M.; Kretschmer, A.; Stief, C. G. und Gratzke, C.
(2017):
Das primäre Prostatasarkom – ein seltenes Malignom.
In: Urologe, Bd. 56, Nr. 7: S. 857-860
2016
Woischke, C.; Blaj, C.; Schmidt, E. M.; Lamprecht, S.; Engel, Jutta; Hermeking, H.; Kirchner, T. und Horst, D.
(2016):
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
In: Oncotarget, Bd. 7, Nr. 21: S. 31350-31360
Rack, A.; Belohradsky, B. H.; Grantzow, R.; Schweinitz, D. v.; Pfluger, T.; Kammer, B.; Girschick, H.; Horst, D. und Wintergerst, U.
(2016):
Inflammatory pseudotumor (IPT)-surgical cure of an inflammatory syndrome.
In: European Journal of Pediatrics, Bd. 175, Nr. 7: S. 903-908
2013
Siemens, H.; Neumann, J.; Jackstadt, R.; Mansmann, Ulrich; Horst, D.; Kirchner, T. und Hermeking, H.
(2013):
Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and beta-catenin predicts distant metastasis of colon cancer.
In: Clinical Cancer Research, Bd. 19, Nr. 3: S. 710-720
2012
Neumann, J.; Horst, D.; Kriegl, L.; Maatz, S.; Engel, Jutta; Jung, A. und Kirchner, T.
(2012):
A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer.
In: Histopathology, Bd. 60, Nr. 3: S. 416-426
Vogler, T.; Kriegl, L.; Horst, D.; Engel, Jutta; Sagebiel, S.; Schaffauer, A. J.; Kirchner, T. und Jung, A.
(2012):
The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
In: Experimental and Molecular Pathology, Bd. 92, Nr. 1: S. 111-117
Beji, A.; Horst, D.; Engel, Jutta; Kirchner, T. und Ullrich, A.
(2012):
Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancer.
In: Clinical Cancer Research, Bd. 18, Nr. 4: S. 956-968
2010
Nagel, J. M.; Kriegl, L.; Horst, D.; Engel, Jutta; Gautam, S.; Mantzoros, C. S.; Kirchner, T.; Göke, Burkhard und Kolligs, F. T.
(2010):
gamma-Catenin is an independent prognostic marker in early stage colorectal cancer.
In: International Journal of Colorectal Disease, Bd. 25, Nr. 11: S. 1301-1309
Kriegl, L.; Horst, D.; Engel, Jutta; Reiche, J. A.; Kirchner, T. und Jung, A.
(2010):
LEF1 and TCF4 expression correlate inversely with survival in colorectal cancer.
In: Journal of Translational Medicine, Bd. 8, Nr. 1: S. 123
2009
Graser, Anno; Stieber, P.; Nagel, D.; Schäfer, C.; Horst, D.; Becker, C.R.; Nikolaou, Konstantin; Lottes, A.; Geisbüsch, Sarah; Kramer, H.; Wagner, A.C.; Diepolder, H.; Schirra, Jörg; Seidel, D.; Göke, Burkhard; Reiser, M.F. und Kolligs, Frank T.
(2009):
Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
In: Gut: S. 241-248
[PDF, 704kB]
Horst, D.; Kriegl, L.; Engel, Jutta; Kirchner, T. und Jung, A.
(2009):
Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
In: Cancer Investigation, Bd. 27, Nr. 8: S. 844-850
Horst, D.; Reu, S.; Kriegl, L.; Engel, Jutta; Kirchner, T. und Jung, A.
(2009):
The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.
In: Cancer, Bd. 115, Nr. 10: S. 2063-2070
Horst, D.; Kriegl, L.; Engel, Jutta; Jung, A. und Kirchner, T.
(2009):
CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer.
In: European Journal of Cancer, Bd. 45, Nr. 11: S. 2034-2040
2008
Horst, D.; Kriegl, L.; Engel, Jutta; Kirchner, T. und Jung, A.
(2008):
CD133 expression is an independent prognostic marker for low survival in colorectal cancer.
In: British Journal of Cancer BJC, Bd. 99, Nr. 8: S. 1285-1289